Recombinant Mycoplasma pneumoniae Uncharacterized lipoprotein MPN_083 (MPN_083), partial

Shipped with Ice Packs
In Stock

Description

Production and Applications

The protein is commercially available for research purposes, primarily in immunological assays such as ELISA, Western blotting, and epitope mapping . Its recombinant production involves:

  • Expression System: E. coli (cost-effective, high yield) .

  • Tags: 6xHis-SUMO for purification and detection .

  • Formats: Liquid (Tris/PBS + glycerol) or lyophilized powder .

Functional Insights from Related Studies

While MPN_083 remains uncharacterized, studies on M. pneumoniae lipoproteins provide context:

  • Regulation: Lipoprotein genes like MPN_199 and MPN_200 are upregulated during host cell adhesion .

  • Surface Exposure: Proteomic studies show extensive cleavage of M. pneumoniae surface proteins, suggesting lipoproteins may undergo processing to interact with host molecules .

  • Immunomodulation: Mycoplasmal lipoproteins activate Toll-like receptors (TLR2/6), driving inflammatory responses .

4.2. Proteolytic Processing

N-terminome analyses of M. pneumoniae identified 4898 unique N-terminal peptides, with ~46% of proteins showing post-translational cleavage . Though MPN_083 was not directly studied, analogous lipoproteins (e.g., MPN052) undergo proteolytic processing to generate immunogenic fragments .

4.3. Immunogenicity

MPN_083 is recognized by polyclonal antibodies in ELISA, confirming its antigenic potential . Its role in macrolide resistance or virulence remains unexplored, unlike M. pneumoniae proteins such as GlpQ (glycerophosphodiesterase) .

Research Gaps and Future Directions

  • Functional Characterization: MPN_083’s role in adhesion, immune evasion, or nutrient acquisition is unknown.

  • Structural Studies: No crystallographic or NMR data exist for this protein.

  • Clinical Relevance: Links to M. pneumoniae-associated diseases (e.g., pneumonia, encephalitis) remain speculative .

Product Specs

Form
Lyophilized powder. We will ship the available format, but if you have specific requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary based on purchase method and location. Consult your local distributor for specific delivery information. All proteins are shipped with standard blue ice packs. For dry ice shipment, please contact us in advance; additional charges apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
MPN_083; MP072; R02_orf533; Uncharacterized lipoprotein MPN_083
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Mycoplasma pneumoniae (strain ATCC 29342 / M129)
Target Names
MPN_083
Uniprot No.

Target Background

Database Links

KEGG: mpn:MPN083

Protein Families
MG067/MG068/MG395 family
Subcellular Location
Cell membrane; Lipid-anchor.

Q&A

What is Mycoplasma pneumoniae and why is MPN_083 significant in research?

Mycoplasma pneumoniae is a wall-less prokaryote that functions as a common respiratory pathogen affecting both children and the elderly . As one of the smallest self-replicating organisms, M. pneumoniae possesses a minimal genome, making it an ideal model system for studying fundamental cellular processes.

The uncharacterized lipoprotein MPN_083 represents one of several predicted lipoproteins in the M. pneumoniae genome. While its specific function remains unknown, bacterial lipoproteins generally play crucial roles in membrane integrity, nutrient acquisition, and host-pathogen interactions. Understanding MPN_083 may provide insights into M. pneumoniae pathogenesis mechanisms.

Methodologically, researchers should begin characterization with bioinformatic approaches, including sequence homology searches, structural prediction, and comparative genomic analysis across related Mycoplasma species before proceeding to experimental validation.

What expression systems are most effective for recombinant MPN_083 production?

Several expression systems can be employed for recombinant MPN_083 production, each offering distinct advantages depending on research objectives:

  • Viral vector systems: The MPN_083 gene can be inserted into modified viral vectors, similar to the approach used for other M. pneumoniae antigens. For example, researchers have successfully inserted M. pneumoniae antigen genes into the nonstructural protein (NS) gene of influenza A virus to create recombinant expression vectors .

  • Bacterial expression systems: E. coli-based systems remain the most accessible option, though codon optimization may be necessary given the different codon usage between M. pneumoniae and E. coli.

  • Reporter gene systems: For in vivo expression studies within M. pneumoniae itself, a promoter-less lacZ gene system has been developed that allows for testing putative promoter fragments .

Methodological considerations should include:

  • Codon optimization for the selected expression host

  • Addition of purification tags (His, GST) that won't interfere with protein function

  • Careful design of constructs to maintain lipidation sites if studying native lipoprotein properties

  • Selection of appropriate secretion signals if membrane localization is desired

How can researchers verify successful expression and purification of MPN_083?

Verification of recombinant MPN_083 expression requires multiple complementary approaches:

Genetic verification:

  • RT-PCR to confirm the presence of the MPN_083 gene in the expression system

  • DNA sequencing to verify the construct sequence integrity

Protein verification:

  • SDS-PAGE analysis to visualize the protein at the expected molecular weight

  • Western blotting using tag-specific antibodies (if a tagged construct was used)

  • Mass spectrometry for definitive protein identification and post-translational modification analysis

The following verification workflow is recommended:

Verification LevelTechniqueExpected ResultsControls
GeneticRT-PCRAmplification band at expected sizePositive: Known M. pneumoniae gene
GeneticSequencingExact match to designed constructReference: Original construct
ProteinSDS-PAGEBand at predicted molecular weightSize markers
ProteinWestern blotSpecific immunoreactive bandPositive: Known tagged protein
FunctionalLipid binding assayMembrane associationKnown lipoprotein control

What are common challenges in M. pneumoniae protein research and how can they be addressed?

Research with M. pneumoniae proteins, including MPN_083, presents several methodological challenges:

Growth and cultivation limitations:
M. pneumoniae is fastidious and slow-growing, making it challenging to obtain sufficient biomass for native protein studies. Researchers should optimize culture conditions and consider recombinant approaches for protein production.

Poor immunogenicity:
M. pneumoniae proteins often exhibit low immunogenicity , complicating antibody production for research applications. Multiple immunization strategies may be necessary, including the use of strong adjuvants or carrier proteins.

Post-translational modifications:
As a lipoprotein, MPN_083 likely undergoes lipidation that may not be properly replicated in heterologous expression systems. Consider specialized expression systems capable of performing Mycoplasma-specific modifications.

Genetic manipulation challenges:
M. pneumoniae has limited genetic tools available compared to model organisms. Transposon mutagenesis has been successfully employed and represents one of the more accessible approaches for genetic studies.

What experimental designs are optimal for functional characterization of MPN_083?

Functional characterization of uncharacterized proteins like MPN_083 requires robust experimental designs that provide multiple lines of evidence:

Transposon mutagenesis approach:
Transposon mutagenesis has been successfully applied to M. pneumoniae and can identify phenotypes associated with MPN_083 disruption. The methodology involves:

  • Generating transposon libraries in M. pneumoniae

  • Screening for insertions in MPN_083

  • Mapping precise insertion sites using techniques like HindIII digestion, religation, and sequencing

  • Phenotypic characterization of mutants

Factorial experimental designs:
For complex phenotypic studies, factorial designs allow testing of multiple variables simultaneously . For MPN_083, a factorial design might examine:

MPN_083 StatusGrowth ConditionHost Cell TypeMeasured Outcome
Wild-typeStandard mediaNoneGrowth rate
MPN_083 mutantStandard mediaNoneGrowth rate
Wild-typeStress conditionNoneGrowth rate
MPN_083 mutantStress conditionNoneGrowth rate
Wild-typeStandard mediaRespiratory epithelialAdhesion efficiency
MPN_083 mutantStandard mediaRespiratory epithelialAdhesion efficiency

This design allows for detecting both main effects and interaction effects between variables, providing richer insights into MPN_083 function .

Within-subject designs:
For experiments examining MPN_083 variants or temporal effects, within-subject designs can reduce variation . This approach is particularly useful when:

  • Comparing different structural variants of MPN_083

  • Examining temporal aspects of host-cell responses to MPN_083

  • Testing MPN_083 under different environmental conditions

How can researchers design studies to resolve contradictory findings about MPN_083 function?

When faced with contradictory results regarding MPN_083 function, researchers should adopt a systematic methodology to resolve discrepancies:

Methodological reconciliation approach:

  • Standardize experimental conditions: Ensure all comparisons use identical:

    • M. pneumoniae strains

    • Growth conditions

    • Protein purification methods

    • Assay conditions

  • Employ multiple independent techniques: For example, if studying membrane localization:

    • Fractionation studies

    • Fluorescence microscopy

    • Protease accessibility assays

    • Lipidomic analysis

  • Control for experimental variables: Implement:

    • Positive and negative controls in each experiment

    • Internal standards for quantitative measurements

    • Blinding procedures when applicable

  • Systematic replication: Design replication studies that:

    • Use increased sample sizes

    • Vary experimental parameters systematically

    • Include statistical power analysis

Research design for resolving contradictions:
Create experiments specifically designed to test competing hypotheses about MPN_083 function. For example, if contradictory results exist regarding its role in adhesion versus immune evasion, design studies that can differentiate between these functions under varied conditions.

What methodologies are appropriate for studying interactions between MPN_083 and host cells?

Investigating MPN_083-host interactions requires specialized approaches:

Protein-protein interaction methodologies:

  • Yeast two-hybrid screening with MPN_083 as bait

  • Co-immunoprecipitation with tagged MPN_083

  • Surface plasmon resonance to measure binding kinetics

  • Cross-linking mass spectrometry to identify interaction interfaces

Cellular response assessment:

  • Transcriptomic analysis of host cells exposed to purified MPN_083

  • Phosphoproteomic studies to identify signaling pathways activated by MPN_083

  • Cytokine profiling to characterize inflammatory responses

Imaging approaches:

  • Immunofluorescence microscopy to localize MPN_083 during infection

  • Live-cell imaging with fluorescently tagged MPN_083

  • Super-resolution microscopy for precise localization studies

Functional validation methodologies:

  • Blocking studies using anti-MPN_083 antibodies

  • Competitive inhibition with recombinant MPN_083 fragments

  • Host cell knockdown/knockout studies of identified interaction partners

How can transposon mutagenesis be optimized for studying MPN_083 function?

Transposon mutagenesis represents a powerful approach for understanding MPN_083 function in vivo . The methodology can be optimized for MPN_083 studies as follows:

Transposon system selection:
M. pneumoniae studies have successfully employed transposon systems with the following features:

  • HindIII restriction sites for mapping insertion locations

  • Promoterless β-galactosidase genes for reporter assays

  • E. coli replication origins for plasmid rescue

MPN_083 targeting strategies:

  • Random mutagenesis approach: Generate large transposon libraries and screen for insertions in MPN_083

  • Directed approach: Design transposons with homology regions flanking MPN_083

  • Multiple insertion strategy: Analyze multiple independent insertions within MPN_083 to correlate phenotypes with specific domains

Insertion mapping methodology:

  • Extract genomic DNA from transposon mutants

  • Digest with HindIII

  • Religate at dilute concentrations

  • Transform into E. coli

  • Select for ampicillin resistance

  • Sequence plasmids to precisely map insertion sites

Phenotypic analysis workflow:

  • Compare growth characteristics between wild-type and MPN_083 mutants

  • Assess changes in membrane properties

  • Evaluate interactions with host cells

  • Measure susceptibility to various stresses

  • Perform complementation studies to confirm phenotype causality

This approach has successfully identified functions for previously uncharacterized M. pneumoniae proteins, including components of ABC-type transport systems that were independently disrupted at multiple sites .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.